GPER1 and cutaneous mastocytosis: The increase in the expression of c-Myc by both flavonoids and by G-1 was significantly reversed when cells were treated with the G-15 antagonist, indicating that this increase in c-Myc was mediating GPER activation by these phytoestrogens, and again confirming the potential therapeutic effect of these flavonoids in management of CM.